Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2009 1
2010 1
2012 1
2019 2
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders.
Okhuijsen-Pfeifer C, van der Horst MZ, Bousman CA, Lin B, van Eijk KR, Ripke S, Ayhan Y, Babaoglu MO, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, Edlinger M, Erdogan IM, Ertuğrul A, Yoca G, Everall IP, Görlitz T; GROUP (Genetic Risk and Outcome of Psychosis) investigators; Grootens KP, Gutwinski S, Hallikainen T, Jeger-Land E, de Koning M, Lähteenvuo M, Legge SE, Leucht S, Morgenroth C, Müderrisoğlu A, Narang A, Pantelis C, Pardiñas AF, Oviedo-Salcedo T, Schneider-Thoma J, Schreiter S, Repo-Tiihonen E, Tuppurainen H, Veereschild M, Veerman S, de Vos M, Wagner E, Cohen D, Bogers JPAM, Walters JTR, Yağcıoğlu AEA, Tiihonen J, Hasan A, Luykx JJ. Okhuijsen-Pfeifer C, et al. Among authors: tuppurainen h. Transl Psychiatry. 2022 Apr 7;12(1):145. doi: 10.1038/s41398-022-01884-3. Transl Psychiatry. 2022. PMID: 35393395 Free PMC article.
BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells.
Bose M, Sachsenweger J, Laurila N, Parplys AC, Willmann J, Jungwirth J, Groth M, Rapakko K, Nieminen P, Friedl TWP, Heiserich L, Meyer F, Tuppurainen H, Peltoketo H, Nevanlinna H, Pylkäs K, Borgmann K, Wiesmüller L, Winqvist R, Pospiech H. Bose M, et al. Among authors: tuppurainen h. Hum Mol Genet. 2019 Dec 15;28(24):4148-4160. doi: 10.1093/hmg/ddz252. Hum Mol Genet. 2019. PMID: 31630195
Navigated and individual α-peak-frequency-guided transcranial magnetic stimulation in male patients with treatment-refractory schizophrenia.
Tuppurainen H, Määttä S, Könönen M, Julkunen P, Kautiainen H, Hyvärinen S, Vaurio O, Joensuu M, Vanhanen M, Aho-Mustonen K, Mervaala E, Tiihonen J. Tuppurainen H, et al. J Psychiatry Neurosci. 2024 Mar 1;49(2):E87-E95. doi: 10.1503/jpn.230063. Print 2024 Jan-Feb. J Psychiatry Neurosci. 2024. PMID: 38428970 Free PMC article. Clinical Trial.
[Restrictions during psychiatric hospitalization].
Repo-Tiihonen E, Putkonen A, Tuppurainen H. Repo-Tiihonen E, et al. Among authors: tuppurainen h. Duodecim. 2012;128(22):2336-43. Duodecim. 2012. PMID: 23342480 Finnish.
Midbrain dopamine D2/3 receptor binding in schizophrenia.
Tuppurainen H, Kuikka JT, Laakso MP, Viinamäki H, Husso M, Tiihonen J. Tuppurainen H, et al. Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):382-7. doi: 10.1007/s00406-006-0649-3. Epub 2006 Jun 16. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16783502